Hyaluronan/Hyaladherins - a Promising Axis for Targeted Drug Delivery in Cancer

Publisher： Bentham Science Publishers

E-ISSN： 1875-5704|13|4|500-511

ISSN： 1567-2018

Source： Current Drug Delivery, Vol.13, Iss.4, 2016-06, pp. : 500-511

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cell Surface Nucleolin as a Promising Receptor for Effective AS1411 Aptamer-Mediated Targeted Drug Delivery into Cancer Cells

By  

Current Drug Delivery, Vol. 15, Iss. 9, 2018-11 ,pp. : 1323-1329

Bentham Science Publishers

Access to resources Recommend Favorite

Targeted Liposomal Drug Delivery in Cancer

By  

Current Pharmaceutical Design, Vol. 10, Iss. 24, 2004-09 ,pp. : 2981-2989

Bentham Science Publishers

Access to resources Recommend Favorite

Cell-derived Exosomes as Promising Carriers for Drug Delivery and Targeted Therapy

By  

Current Cancer Drug Targets, Vol. 18, Iss. 4, 2018-04 ,pp. : 347-354

Bentham Science Publishers

Access to resources Recommend Favorite

Functionalized Micellar Systems for Cancer Targeted Drug Delivery

By Sutton Damon   Nasongkla Norased   Blanco Elvin   Gao Jinming  

Pharmaceutical Research, Vol. 24, Iss. 6, 2007-06 ,pp. : 1029-1046

Springer Publishing Company

Access to resources Recommend Favorite

Nanomaterials for targeted drug delivery to cancer stem cells

By Orza Anamaria   Casciano Daniel   Biris Alexandru  

Drug Metabolism Reviews, Vol. 46, Iss. 2, 2014-05 ,pp. : 191-206

Informa Healthcare

Access to resources Recommend Favorite